![Hunter Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hunter Smith
Financieel Directeur/CFO bij
RHYTHM PHARMACEUTICALS, INC.
Vermogen: 12 M $ op 31-07-2026
Profiel
Hunter C.
Smith is currently Director at Vanqua Bio, Inc. and Chief Financial Officer & Treasurer at Rhythm Pharmaceuticals, Inc. since 2021.
Former roles include Independent Director at Genesee & Wyoming, Inc. from 2015 to 2019, Independent Director at Spyre Therapeutics, Inc. from 2021 to 2023, Director-Commodities Finance at UBS AG (Stamford Branch) from 1992 to 1999, CFO-Inflammation & Immunology and VP-Finance at Celgene Corp.
from 2013 to 2017, Chief Financial Officer-Sugar & Bioenergy Segment at Bunge Ltd. from 2010 to 2013, and Credit Analyst at Manufacturers Hanover Corp.
from 1990 to 1992.
Education includes undergraduate studies at Northwestern University and an MBA from The Leonard N Stern School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-05-2026 | 119.611 ( 0,17% ) | 12 M $ | 31-07-2026 |
Actieve functies van Hunter Smith
| Bedrijven | Functie | Begin |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 01-07-2017 |
Vanqua Bio, Inc.
 Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Directeur/Bestuurslid | - |
Eerdere bekende functies van Hunter Smith
| Bedrijven | Functie | Einde |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Directeur/Bestuurslid | 22-11-2023 |
| GENESEE & WYOMING INC. | Directeur/Bestuurslid | 30-12-2019 |
| CELGENE | Corporate Officer/Principal | 01-07-2017 |
Bunge Ltd.
 Bunge Ltd. Agricultural Commodities/MillingProcess Industries Engages in the agriculture and food businesses | Public Communications Contact | 01-01-2003 |
UBS AG (Stamford Branch)
 UBS AG (Stamford Branch) Financial ConglomeratesFinance Provides financial and investment services | Corporate Officer/Principal | 01-01-1999 |
Opleiding van Hunter Smith
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
68
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Genesee & Wyoming, Inc.
 Genesee & Wyoming, Inc. RailroadsTransportation Provides rail freight transportation services | Transportation |
Bunge Ltd.
Bunge Ltd. Agricultural Commodities/MillingProcess Industries Engages in the agriculture and food businesses | Process Industries |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UBS AG (Stamford Branch)
UBS AG (Stamford Branch) Financial ConglomeratesFinance Provides financial and investment services | Finance |
Manufacturers Hanover Corp.
 Manufacturers Hanover Corp. Financial ConglomeratesFinance Operates as a bank holding company | Finance |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanqua Bio, Inc.
Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Commercial Services |
